Dr. Bryan J. Winn, MD

Dr. Winn practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Winn's NPI, 1629279799, was assigned on May 29, 2007. Dr. Winn graduated from Vagelos College of Physicians and Surgeons in 2003. Dr. Winn's New York license number on file is 251709.

Dr. Winn's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Winn's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Winn to 5 more medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Winn practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Winn's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Winn is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Winn's licenses on file in 3 states: New York, California and New Jersey.

Dmand AI lists conjunctivitis, eye infection or inflammation, eyelid inflammation and vision problems among the conditions Dr. Winn treats.

CMS data shows 204 Medicare services from Dr. Winn across 5 procedure codes in 2024, for 181 Medicare patients. Medicare paid $10,884 for them.

CMS counts 181 Medicare patients who saw Dr. Winn in 2024. The largest group is 65 to 74, with 88 patients. 74% of them have high cholesterol, and 59% have high blood pressure. 29% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Winn's median patient age at 70, with 61% women.

In 2024, Dr. Winn wrote 134 Medicare Part D claims for 76 patients. 94% of them were for generic drugs. CMS names the drug for 79 of them, across 1 drug with 11 or more claims each, at $807 in total drug cost. In 2023, CMS named 105 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Winn for performance year 2024, reported as part of a group. Dr. Winn accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Winn as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 62 papers to Dr. Winn, published from 2008 to 2025. 2022 was the busiest year, with 10. The most frequent topics are Blepharoptosis, Magnetic Resonance Imaging and Orbital Diseases. Dr. Winn has published most often in Ophthalmic Plast Reconstr Surg. Dr. Winn's most frequent co-authors are Seanna Rae Grob, MAS, MD, Meleha Taj Ahmad, MD and Lora Rabin Dagi Glass, MD.

Dmand AI links Dr. Winn to 1 clinical trial. Conditions studied include Graves Ophthalmopathy and Exophthalmos.

CMS Open Payments shows 29 general payments to Dr. Winn from 9 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 92% of the total. Genentech, Inc. paid the most, $8,775.

Dmand AI lists 1 award for Dr. Winn.

Dr. Winn graduated from Vagelos College of Physicians and Surgeons in 2003. Dr. Winn is a member of AAO and American Society of Ophthalmic Plastic and Reconstructive Surgery.

Dr. Winn is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.